Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Disturbances in Heart Rhythm

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...

Dysrhythmias IV: Characteristics of Bradyarrhythmias

Dysrhythmias IV: Characteristics of Bradyarrhythmias

Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Induction of ventricular fibrillation during both left ventricular and right atrial radiofrequency ablation with a dual energy lattice-tip ablation catheter in patient with implantable cardioverter defibrillator.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing·2026

Same author

The Role of Ethanol Ablation of the Vein of Marshall in the Era of Pulsed Field Ablation.

Journal of clinical medicine·2026

Same author

Bachmann's Bundle-Related Atrial Tachycardias Following Catheter Ablation of Persistent Atrial Fibrillation.

Journal of cardiovascular electrophysiology·2026

Same author

Acute sinus node dysfunction requiring a permanent pacemaker after ethanol ablation of the vein of Marshall.

HeartRhythm case reports·2025

Same author

Prognostic Value of Antiarrhythmic Drug Suppression of Electrical Storm Prior to Ventricular Tachycardia Ablation.

Journal of cardiovascular electrophysiology·2025

Same author

Improvement in Mitral Regurgitation After Catheter Ablation of Premature Ventricular Complexes.

Journal of cardiovascular electrophysiology·2025

Search research articles

Related Experiment Video

Updated: Jun 16, 2026

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology

Published on: May 26, 2015

A critical decrease in dominant frequency and clinical outcome after catheter ablation of persistent atrial

Kentaro Yoshida¹, Aman Chugh, Eric Good

¹Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, Michigan, USA.

|February 2, 2010

Summary

This summary is machine-generated.

A 11% decrease in dominant frequency (DF) during radiofrequency ablation (RFA) for persistent atrial fibrillation (AF) predicts successful outcomes. This finding offers a potential endpoint for RFA, simplifying procedures and improving success rates.

More Related Videos

Determination of Continuity Index Values in Atrial Fibrillation Ablation with Proactive Esophageal Cooling

Determination of Continuity Index Values in Atrial Fibrillation Ablation with Proactive Esophageal Cooling

Published on: April 19, 2024

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

Related Experiment Videos

Last Updated: Jun 16, 2026

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology

Published on: May 26, 2015

Determination of Continuity Index Values in Atrial Fibrillation Ablation with Proactive Esophageal Cooling

Determination of Continuity Index Values in Atrial Fibrillation Ablation with Proactive Esophageal Cooling

Published on: April 19, 2024

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

Area of Science:

Cardiology
Electrophysiology
Medical Technology

Background:

Radiofrequency ablation (RFA) for persistent atrial fibrillation (AF) often requires extensive procedures and long durations.
Identifying optimal endpoints for RFA can improve procedural efficiency and patient outcomes.

Purpose of the Study:

To evaluate if a critical decrease in the dominant frequency (DF) of AF serves as a sufficient endpoint for RFA in persistent AF.
To determine the predictive value of DF changes for maintaining sinus rhythm post-ablation.

Main Methods:

100 patients with persistent AF underwent antral pulmonary vein isolation (APVI) and RFA of complex fractionated atrial electrograms (CFAEs).
Fast Fourier Transform (FFT) analysis was used to measure DF in lead V1 and the coronary sinus at baseline and before RFA termination.
A critical decrease in DF was assessed for its prediction of sinus rhythm post-RFA.

Main Results:

A decrease in DF of ≥11% accurately predicted freedom from atrial arrhythmias (sensitivity 0.71, specificity 0.82).
Patients with ≥11% DF decrease maintained sinus rhythm off antiarrhythmic drugs in 77% of cases at 14 months, compared to 23% with <11% decrease (P <.001).
RFA duration and total procedure time were significantly shorter in patients without AF termination or with a ≥11% DF decrease.

Conclusions:

A ≥11% decrease in DF during RFA for persistent AF is associated with a high probability of maintaining sinus rhythm.
This DF decrease serves as a reliable endpoint, potentially reducing procedure time and complexity.
The study suggests that DF monitoring can guide RFA, offering an alternative to complete AF termination for achieving long-term sinus rhythm.